Background
Early initiation of ART can preserve immune function and is associated with increased incidence of post-treatment control of HIV, yet differences in HIV-specific immune responses between people with HIV (PWH) who initiated ART during acute vs. chronic infection are poorly defined. The extent to which immune responses in early- and late-treated PWH differ from those of elite controllers (ECs)–who exhibit ART-free control of HIV–has also not been fully evaluated. We used CyTOF to compare the frequencies, phenotypes, and effector functions of HIV-specific CD8+ T cells in longitudinal blood specimens from PWH who began ART during acute or chronic infection and from ECs.
Methods
PBMC collected prior to ART and up to 4 timepoints after ART initiation were obtained from the UCSF SCOPE cohort (n = 16 acute, n = 10 chronic, n = 10 ECs). Cells were analyzed using a 40-parameter CyTOF panel at baseline and following a 6-hour stimulation with peptides spanning the HIV proteins Gag, Pol, Env, Tat, and Nef. HIV-specific T cells were assessed using a combination of 9 effector cytokines/chemokines and 3 cytolytic/degranulation markers.
Results
In all cohorts, most HIV-specific T cells induced IFNg, TNFa, and the degranulation marker CD107a. Prior to ART, HIV-specific CD8+ T cell frequencies were higher in the chronic-treated and EC cohorts compared to the acute-treated cohort. Pre-ART, expression of CTLA-4, a marker of cellular exhaustion, was elevated on HIV-specific CD8+ T cells from the chronic-treated and EC groups relative to the acute-treated group (p<0.004). However, expression of the follicle-homing receptor CXCR5 was uniquely elevated on HIV-specific CD8+ T cells from ECs compared to the other groups (p<0.0005). After ART, HIV-specific CD8+ T cell frequencies declined in ECs (p<0.005) but remained unchanged in the acute and chronic-treated groups.
Conclusions
Our data suggest that the frequencies of HIV-specific CD8+ T cells are decreased by ART in ECs, but not in acute or chronic-treated PWH. HIV-specific CD8+ cells from ECs, like those from chronic-treated PWH, expressed the exhaustion marker CTLA4, possibly due to chronic antigen stimulation. However, HIV-specific CD8+ T cells from ECs uniquely express high levels of CXCR5, which may help direct these effector cells to lymphoid follicles, a primary site of HIV persistence. Our findings suggest that HIV-specific CD8+ T cells in ECs have distinguishing phenotypic features that may explain their ability to mediate ART-free HIV control.
Table or Figure
![]()